iXensor Co., Ltd. (TPEX:6734)
Taiwan · Delayed Price · Currency is TWD 8.32
+0.12 (1.46%)
Feb 11, 2026, 2:59 PM CST
iXensor Revenue
iXensor had revenue of 12.54M TWD in the half year ending June 30, 2025, with 10.11% growth. This brings the company's revenue in the last twelve months to 24.59M, up 45.38% year-over-year. In the year 2024, iXensor had annual revenue of 19.46M, down -6.85%.
Revenue (ttm)
24.59M
Revenue Growth
+45.38%
P/S Ratio
10.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
254.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.46M | -1.43M | -6.85% |
| Dec 31, 2023 | 20.89M | -84.35M | -80.15% |
| Dec 31, 2022 | 105.24M | 80.44M | 324.44% |
| Dec 31, 2021 | 24.79M | 8.87M | 55.70% |
| Dec 31, 2020 | 15.92M | -14.11M | -46.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| AViTA | 896.85M |
| Bioptik Technology Incorporation | 829.18M |
| EPS Bio Technology | 497.19M |
| Health & Life | 441.84M |
| Radiant Innovation | 413.06M |
| Wiltrom | 338.37M |
| S&S Healthcare Holding | 205.64M |